Atavistik Bio
Cambridge
About Atavistik Bio
Atavistik Bio is a biotechnology company that specializes in the discovery and development of precision allosteric small molecules aimed at treating metabolic diseases and cancer. The company aims to revolutionize therapeutic approaches by focusing on selective allosteric therapeutics, which can potentially transform treatment options for serious diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $260.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2026)
- Website: atavistikbio.com
Industries & Categories
Biotechnology, Health Care, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/atavistik-bio-35419 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.